Prediction of conversion of mild cognitive impairment to Alzheimer’s dementia: a comparison of different PET and CSF amyloid markers

282 null Aim: null null Amyloid PET is an established biomarker for the prognosis of conversion from mild cognitive impairment (MCI) to Alzheimer’s dementia (AD), but the optimal evaluation method is still under debate. In this work, three methods for the evaluation of amyloid PET are compared amongst each other and with the amyloid-β ratio Aβ42/Aβ40 in cerebrospinal fluid (CSF). null Methods: null null AV45 PET data of 319 MCI patients from...